The discrepancies could be assigned to the presence of 'atypical' TCRD gene rearrangements or translocations only detectable by SB, but also to efficient PCR-based detection of rearrangements derived from small subclones, which are difficult to detect with SB. Indications for oligoclonality were observed in 38% and 30% of patients with TCRG and TCRD gene rearrangements, respectively, which is comparable to the frequency of oligoclonality in IGH locus. Based on the combined data it was possible to reduce the broad panel of six TCRD and 12 TCRG primer combinations for MRD studies to two TCRD combinations (V␦2-D␦3 and D␦2-D␦3) and six TCRG combinations (V␥I, V␥II, V␥IV family-specific primers with J␥1.1/2.1 and J␥1.3/2.3 primers) resulting in the detection of 80% and 97% of all TCRD and TCRG gene rearrangements, respectively. Finally, the heteroduplex PCR data indicate that MRD monitoring with TCRG and/or TCRD targets is possible in approximately 80% of childhood precursor-B-ALL patients; ෂ55% of patients even have two TCRG and/or TCRD targets.
Introduction
The enormous diversity of immunoglobulin (Ig) and T cell receptor (TCR) molecules is generated during B and T cell differentiation by a series of ordered rearrangements of variable Correspondence: Prof JJM van Dongen, Dept of Immunology, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands; Fax: 31 10 4367601 Received 10 September 1998; accepted 22 October 1998 (V), diversity (D) and joining (J) gene segments. 1, 2 Initially, Ig and TCR gene rearrangements were regarded as B-lineage and T-lineage specific markers, respectively. However, the finding of cross-lineage expression of 'lineage-specific' immunological markers and cross-lineage Ig and TCR gene rearrangements has disputed this view. 2, 3 Cross-lineage rearrangements of Ig heavy-chain (IGH) genes have been observed in 10-15% of T acute lymphoblastic leukemia (T-ALL) and in ෂ5% of mature T cell leukemias and lymphomas, but cross-lineage rearrangements of Ig light chain genes in malignant T cell proliferations are rare (Ͻ1%). [4] [5] [6] On the other hand, TCR beta (TCRB), TCR gamma (TCRG) and TCR delta (TCRD) gene rearrangements and/or deletions have been found in ෂ30%, ෂ50% and ෂ80% of precursor-B-ALL, respectively.
5- 13 However, only a few limited studies have described the configuration of all three TCR genes in precursor-B-ALL. 5, 7, 10, 11 The detection of rearrangements in the TCR alpha (TCRA) locus by Southern blotting (SB) and PCR is difficult due to the long stretch of J␣ gene segments (about 85 kb) (Figure 1 ), but the occurrence of TCRA gene rearrangements in precursor-B-ALL can be deduced from TCRD gene deletions. Therefore, whenever TCRD gene deletions are detected, rearrangements in the TCRA locus can be anticipated.
Junctional regions of rearranged Ig and TCR genes in lymphoid malignancies can be regarded as clonal 'tumor-specific' markers, because they arise during the recombination of different V, (D) and J gene segments by deletion and random insertion of nucleotides at the junctions of the gene segments. 1 Hence, each junctional region of rearranged Ig and TCR genes is different in each leukemia and lymphoma. Therefore, the polymerase chain reaction (PCR) has been used for amplification of the 'tumor-specific' junctional regions of crosslineage rearranged TCRG and TCRD genes to detect minimal residual disease (MRD) in precursor-B-ALL. [14] [15] [16] [17] The aims of our study were firstly to determine the precise frequency of cross-lineage TCR gene rearrangements in a large series of childhood precursor-B-ALL and to evaluate the occurrence of preferential TCR gene rearrangements and the occurrence of oligoclonality at the TCR gene level. Secondly, based on SB data we estimated the number of precursor-B-ALL patients with identifiable cross-lineage TCR gene rearrangements, which can be used for PCR-mediated MRD detection. Thirdly, we wished to evaluate whether heteroduplex analysis of PCR products can be used for reliable identification of rearranged TCRG and TCRD genes as molecular targets for MRD monitoring, because heteroduplex PCR analysis was shown to be a rapid, cheap, non-radioactive, and easy alternative approach for detection of clonal Ig and TCR gene rearrangements with a sensitivity of 1-5%. [18] [19] [20] [21] The configuration of the TCRB, TCRG and/or TCRD genes was analyzed by SB in 202 well-characterized cases of precur- 197   TCRA  TCRD  and  gene complex (# 14q11) TCRB gene complex (# 7q35) TCRG gene complex (# 7p14-15) sor-B-ALL and the results were compared with previously published childhood precursor-B-ALL cases. In addition, 62 precursor-B-ALL patients were subjected to detailed heteroduplex PCR analysis of the TCRG and TCRD gene loci.
Materials and methods

Cell samples
Bone marrow (BM) or peripheral blood (PB) samples from 202 children with precursor-B-ALL were obtained at initial diagnosis. The age distribution was from 2 months until 16 years and 6 months (mean 5 years and 8 months). Twenty-five chilkb   control  control  control  3264  4678  3829  4745  4511  4513  3995  3178  4535 kb kb 5.8 -
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Figure 2
SB analysis of TCR genes in several precursor-B-ALL patients. Control DNA and DNA from precursor-B-ALL patients were digested with the appropriate restriction enzymes, size-separated and blotted onto nylon membrane filters, which were hybridized with dren were younger than 2 years and eight of them were infants (age Ͻ1 year). The diagnosis of ALL was made according to the FAB classification 22 and was always confirmed by the laboratory of the Dutch Childhood Leukemia Study Group.
Mononuclear cells (MNC) were isolated from PB or BM samples by Ficoll-Paque centrifugation (density 1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden). The freshly obtained MNC samples were subjected to a detailed immunophenotyping according to standard protocols. [23] [24] [25] Remaining MNC were stored in liquid nitrogen. A leukemia was considered to be a precursor-B-ALL if the malignant cells were positive for terminal deoxynucleotidyl transferase (TdT), CD19 and HLA-DR (pro-B-ALL), for TdT, CD10, CD19 and HLA-DR (common ALL), or for TdT, CD10, CD19, HLA-DR and cytoplasmic Ig heavy-chain (CyIg) (pre-B-ALL). Immunological marker analysis of the precursor-B-ALL revealed that eight were pro-B-ALL, 135 were common ALL, and 59 were pre-B-ALL.
Southern blot analysis
DNA was isolated from fresh or frozen MNC fractions as described previously. 2 Fifteen micrograms of DNA were digested with the appropriate restriction enzymes (Pharmacia), size-separated in 0.7% agarose gels and transferred to Nytran-13N nylon membranes (Schleicher and Schuell, Dassel, Germany) as described. 2 Incomplete and complete TCRB gene rearrangements were detected with TCRBD1U, TCRBD1, TCRBJ1, TCRBD2U, TCRBD2, TCRBJ2 and TCRBC probes (Ref. 47 ; DAKO Corporation, Carpinteria, CA, USA) in EcoRI and HindIII digests. TCRG gene rearrangements were analyzed with the J␥1.2 probe in BglII digests and the J␥1.3 and J␥2.1 probes in EcoRI digests. 2, 26, 27 The configuration of the TCRD genes was analyzed with the TCRDJ1 probe in BglII, Table 2 Allelic frequencies of TCRB gene rearrangements in 196 childhood precursor-B-ALL patients as detected by SB analysis 
The number of indicated alleles includes two precursor-B-ALL patients showing three monoclonal rearrangements, most probably as a result of trisomy 7. b The number of rearrangements is higher than the number of rearranged alleles, because of the incidental occurrence of subclones in these patients.
EcoRI and HindIII digests and in 102 cases additionally with TCRDV1, TCRDV2, TCRDV3, TCRDRE, TCRDD1, TCRDD3, TCRDJ2, TCRDJ3, TCRDC, and TCRAPJ probes (DAKO Corporation).
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PCR amplification
Sixty-two precursor-B-ALL patients were subjected to detailed PCR study of TCRG and TCRD gene loci. PCR was essentially performed as described previously. 13, 28, 29 In each 100 l PCR reaction 0.1 g DNA sample, 12.5 pmol of the 5Ј and 3Ј oligonucleotide primers, and 1 U Taq polymerase (PE Biosystems, Foster City, CA, USA) were used. The sequences of the majority of oligonucleotides used for amplification of TCRG and TCRD gene rearrangements were published before. 13, 29 Some primers were newly designed during the BIOMED-1 Concerted Action 'Investigation of minimal residual disease in acute leukemia: international standardization and clinical evaluation'. 30 All primers were synthesized on an ABI 392 
a Since frequencies of particular TCRG gene rearrangements are slightly different in the group studied by heteroduplex PCR analysis from the total group analyzed by SB, both groups are described separately. b Excluding weak gene rearrangements detected by SB probably derived from subclones.
DNA synthesizer (PE Biosystems) using the solid-phase phosphotriester method. PCR conditions were: initial denaturation step of 3 min at 92°C followed by 45 s at 92°C, 90 s at 60°C, and 2 min at 72°C for 35 cycles using a PE Biosystems thermal cycler. After the last cycle an additional extension step of 10 min at 72°C was performed. Appropriate positive and negative controls were included. 30 
Heteroduplex analysis of PCR products
For heteroduplex analysis, the PCR products were denatured at 94°C for 5 min after the final cycle of amplification and subsequently cooled to 4°C for 60 min to induce duplex formation. 19 Afterwards the duplexes were immediately loaded on 6% non-denaturing polyacrylamide gels in 0.5 × Tris-Boric acid-EDTA (TBE) buffer, run at room temperature, and visualized by ethidium bromide staining. 19 PstI-digested lambda DNA or a 100-bp DNA ladder (Promega Corporation, Madison, WI, USA) were used as size markers.
Both SB and heteroduplex analysis of PCR products were performed in parallel in a double-blind manner. Concordance between the two methods was calculated assuming that the following gene configurations concerned the same alleles: rearranged band in SB = presence of clonal homoduplex after PCR; germline band and/or deletion in SB = no clonal PCR product.
Results
SB analysis of TCRB gene rearrangements
DNA samples from 196 precursor-B-ALL at diagnosis were examined for the presence of rearranged TCRB genes by SB (Figure 2a) . In all eight pro-B-ALL no TCRB gene rearrangements were detected. In common ALL and pre-B-ALL, TCRB gene rearrangements were detected in 40% (51/129) and 31% (18/59), respectively ( Table 1 ). The allelic frequencies of TCRB gene rearrangements are summarized in Table 2 . Germline configuration was found in 75% (294/394) of the TCRB alleles. No rearrangements were detected with the TCRBD1 and J␤1 probes; only rearrangements in the TCRB2 locus were observed. The majority concerned complete V(D)J␤2 rearrangements (53%) or incomplete D␤-J␤2 rearrangements (33%) ( Table 2 ). In six patients (3%), SB analysis revealed weak bands, most probably derived from subclones.
SB analysis of TCRG gene rearrangements
Diagnosis DNA samples from 192 precursor-B-ALL patients were analyzed by SB for the presence of rearranged TCRG genes (Figure 2b ). We detected TCRG gene rearrangements in 59% (113/192) of precursor-B-ALL; this finding concerned monoallelic rearrangements in 35% (39/113) and biallelic rearrangements in 65% (74/113). The distribution of the TCRG gene rearrangements in the three precursor-B-ALL subgroups was 13% (1/8) in pro-B-ALL, 63% (79/125) in common ALL, and 56% (33/59) in pre-B-ALL (Table 1 ). The allelic frequencies of TCRG gene rearrangements are summarized in Table 3 . TCRG genes in germline configuration were found in 51% of alleles. Rearrangements to J␥1.3 or J␥2.3 gene segments predominated, comprising 70% of recombinations, while J␥1.1 or J␥2.1 gene rearrangements were found in the vast majority of the remaining cases. Whenever SB allowed a reliable discrimination between J␥1 and J␥2 gene rearrangements (Figure 1 ) (172 of the 187 rearranged alleles), we found that approximately 70% of the TCRG gene rearrangements occurred to J␥1 gene segments.
V gene segments of the V␥I family were used most frequently (70%), followed by V␥II (V␥9) (22%) and V␥IV(V␥11) (6%). In up to 10% of all patients (19/192) , ie 17% (19/113) of patients with TCRG gene rearrangements, either multiple bands of heterogeneous densities or weak bands in addition to germline bands were found suggesting oligoclonality in the TCRG locus (Figure 3) . Five clonal PCR products were found in patient 5566, and three in patient 5575. There was no obvious difference in the intensity of homoduplexes between true 'allelic' rearrangements (patient 5531) and recombinations derived from subclones (patient 5575).
SB analysis of TCRD gene rearrangements
DNA samples from 202 precursor-B-ALL were analyzed for the presence of TCRD gene rearrangements and/or deletions (Figure 2c ). In the total group of precursor-B-ALL patients monoallelic or biallelic TCRD gene rearrangements were found in 55% (112/202) and monoallelic or biallelic TCRD gene deletions in the absence of TCRD rearrangements were found in 34% (68/202), equally distributed over the three different precursor-B-ALL subgroups ( Table 1 ). The allelic frequencies of germline TCRD genes (21%), TCRD gene rearrangements (40%), and deletions (39%) are summarized in Table 4 . In 67% of rearranged alleles a V␦2-D␦3 rearrangement and in 13% a D␦2-D␦3 rearrangement was found. The remaining TCRD gene rearrangements detected by use of the J␦1 probe could not be identified precisely. They are probably caused either by rearrangements of a V␣ gene segment to the D␦3-J␦1 region or by translocations or other chromosomal aberrations in the TCRD locus.
In addition, 102 patients were subjected to detailed SB TCRD analysis with multiple V␦, D␦, J␦ probes as well as C␦, ␦REC and J␣ probes. Rearrangements of V␦ or D␦ gene segments in the absence of the C␦ gene region allowed us to conclude that in 36% (36/102) of the TCRD gene deletions a V␦2 or D␦2 gene segment most likely rearranged to a J␣ gene segment (Figure 2c) . Furthermore, we assume that in the majority of TCRD gene deletions (60%) a V␣-J␣ gene rearrangement occurred, because upon hybridization with all TCRD and J␣ probes no hybridization signal was observed. In four precursor-B-ALL patients (five alleles) a unique hybridization pattern was found in which V␦ (except for the V␦3 probe), ␦REC and D␦1 probes resulted in germline hybridization signals, whereas all J␦, C␦ and the J␣ probes showed no hybridization signal, indicating deletion of these DNA gene segments. Therefore, it cannot be excluded that potential targets for rearrangements are present within the D␦2-D␦3 region or that chromosome aberrations in the TCRD/A locus are present. In four patients three TCRD gene rearrangements of identical intensity were found suggesting trisomy 14 (Table 4 and Figure 4) . In up to 7% (15/202) of precursor-B-ALL patients, ie 13% (15/112) of cases with TCRD gene rearrangements, the presence of additional weak SB bands suggested oligoclonality.
Comparison of SB and heteroduplex PCR analysis of TCRG and TCRD
DNA-based PCR amplification was simultaneously performed with SB analysis in a double-blind manner for TCRG and TCRD genes in 62 cases. Heteroduplex PCR analysis of TCRG with 12 primer pair combinations (four V␥ family-specific primers with J␥1.1/2.1, J␥1.2 and J␥1.3/2.3 primers) revealed all except one allelic gene rearrangements detected by the SB technique. In seven cases with TCRG gene rearrangements estimated as monoallelic based on SB, two homoduplexes were found, indicating the presence of two rearrangements of the same gene segments. Furthermore, with the same primer combinations we were able to amplify 10 minor TCR gene rearrangements, demonstrated by SB analysis as weak bands (Figure 3 ). They were visualized as 12 homoduplexes of intensities equal to products derived from monoallelic gene rearrangements. Finally, nine rearrangements were detected exclusively by heteroduplex PCR analysis (six rearrangements to J␥1.1/2.1, two V␥II-J␥1.3/2.3, and one V␥IV-J␥1.3/2.3 Using six primer pair combinations for heteroduplex PCR analysis of TCRD (V␦1-J␦1, V␦2-J␦1, V␦3-J␦1, V␦2-D␦3, D␦2-D␦3, D␦2-J␦1) we have not found any clonal PCR products of rearrangements to the J␦1 segment. Moreover, samples shown by SB to contain clonal V␦2-D␦3 gene rearrangements revealed monoclonal homoduplexes in all but four cases (Figure 4) . In those four patients heteroduplex PCR analysis showed an oligoclonal pattern of the V␦2-D␦3 joining. All samples found by SB to contain clonal D␦2-D␦3 recombinations were also monoclonal in heteroduplex PCR analysis (Figure 4 ). This also concerned weak SB bands, probably derived from subclones. In cases, when 'atypical' rearrangements to D␦3/J␦1 locus were detected with SB (the sizes of clonal bands could not be assigned to a particular V␦-J␦ joining) we did not find any clonal PCR products with the applied primer sets. Based on combined SB and PCR data there was an evidence for oligoclonality in TCRD gene locus in up to 21% of precursor-B-ALL patients (13/62), ie 30% (13/43) of the patients with TCRD gene rearrangements. The overall concordance between SB and heteroduplex PCR analysis for detection of clonal TCRG and TCRD gene rearrangements ranged from 78 to 87%.
Combinations of cross-lineage TCR gene rearrangements based on SB analysis
The different combinations of cross-lineage TCR gene rearrangements in our total group of precursor-B-ALL are summarized in Table 5 . Twenty-seven percent of all precursor-B-ALL patients had simultaneously rearranged and/or deleted TCRB, TCRG and TCRD genes. These combined rearrangements were not found in eight pro-B-ALL patients, whereas in common ALL and pre-B-ALL 30% and 25% of cases had all three TCR genes rearranged or deleted.
Twenty-six percent of all precursor-B-ALL cases showed TCRD gene rearrangements and/or deletions, with germline TCRB and TCRG genes. In contrast, TCRB and/or TCRG gene rearrangements without TCRD gene rearrangements and/or deletions were observed in only 4% of cases. Similarly, 32% of all precursor-B-ALL cases had a rearranged TCRG gene with a germline TCRB gene, while only 8% showed TCRB gene rearrangements without TCRG gene rearrangements. These data indicate that TCRD gene rearrangements and/or deletions occur most frequently and that virtually all TCRB and TCRG rearrangements coincide with TCRD gene rearrangements and/or deletions.
Discussion
We investigated a large group of 202 precursor-B-ALL patients for the configuration of their cross-lineage TCR gene rearrangements. Rearrangements and/or deletions of the TCRB, TCRG and TCRD genes were found in 35%, 59% and 89%, respectively. Most TCRB gene rearrangements (53%) were monoallelic complete V(D)J␤2 rearrangements, TCRG genes most frequently (ෂ70%) contained rearrangements to the J␥1 gene segments, and 80% of TCRD gene rearrangements represented incomplete V␦2-D␦3 or D␦2-D␦3 rearrangements, which is in agreement with previously published data.
5-12 Our earlier literature review on cross-lineage TCR gene configuration in childhood precursor-B-ALL, 6 suggested that TCRB gene rearrangements occur in 33% of precursor-B-ALL, TCRG gene rearrangements in 44%, and TCRD gene rearrangements and deletions in 57% and 26%, respectively. These percentages of TCR gene rearrangements and/or deletions are all lower than in the current study of childhood precursor-B-ALL (Table 1) . This difference is probably due to the extended panels of TCR DNA probes and restriction enzymes used for this study. 2, 13, 27 Ig and TCR gene rearrangements can be missed when only one DNA probe is used in combination with a single restriction enzyme, especially when this results in large germline restriction fragments. Furthermore, especially the use of upstream and downstream D␤ probes has given more detailed insight in the configuration of the TCRB locus. We found a significantly higher frequency of incomplete TCRB gene rearrangements (42% of all TCRB gene rearrangements) than reported previously (Table 2) . control  control  5135  5135  5324  5324  5380  5380  5399 5399
Figure 4
Clonality assessment via SB analysis and heteroduplex PCR analysis of TCRD genes. (a) DNA from precursor-B-ALL patients was digested with BglII and EcoRI. The filter was hybridized with the 32 P-labeled TCRDJ1 probe. Based on SB band intensity and sizes 'triallelic' TCRD rearrangement was assumed in patients 5324 (two times V␦2-D␦3, and single D␦2-D␦3) and 5380 (two times D␦2-D␦3, and single V␦2-D␦3), and biallelic in patients 5135 (V␦2-D␦3 and ?-D␦3/J␦1) and 5399 (V␦2-D␦3 and D␦2-D␦3), respectively. (b) Heteroduplex PCR analysis with V␦2 and D␦2 primers in combination with a D␦3 primer showed fully concordant results with SB analysis. ss, single-strand fragments; he, heteroduplexes; ho, homoduplexes; Mw marker, 100-bp molecular weight marker. This is most probably owing to the usage of the four different D␤ probes, which allow identification of incomplete V-D␤, D-D␤, and D-J␤ gene rearrangements. 47 Four other research groups analyzed and compared all three cross-lineage TCR genes in a total number of 100 cases. 5, 7, 10, 11 Combining these published data and the data presented here show that TCRD gene rearrangements and/or deletions occurred in the majority of cases (ෂ90%) and that 27% of childhood precursor-B-ALL had TCRD gene rearrangements and/or deletions with germline TCRG and TCRB genes (Table 5 ). In contrast, TCRG and/or TCRB gene rearrangements without TCRD gene rearrangements and/or deletions were found in only 3% (9/292) of cases (Table 5) . Similarly, 29% (87/292) of precursor-B-ALL cases had rearranged TCRG genes with germline TCRB genes, while only 8% (23/292) showed TCRB gene rearrangements without TCRG gene rearrangements (Table 5) . Apparently in precursor-B-ALL, similarly to the hierarchy during early T cell development, rearrangements in the TCRD locus occur first, followed by TCRG gene rearrangements, and subsequently by TCRB gene rearrangements.
The frequencies of cross-lineage TCR gene rearrangements seem to be related to the maturation stages of B cells. The frequency of TCR gene rearrangements is lower in immature precursor-B-ALL (pro-B-ALL) as compared to CD10
+ precursor-B-ALL (common ALL and pre-B-ALL) ( Table 1 ) and if present, rearrangements exclusively concern a single locus in pro-B-ALL. When comparing our common ALL and pre-B-ALL subgroups, it is striking that in the 'mature' (CyIg + ) pre-B-ALL group a higher frequency of patients have all TCR genes in germline configuration (15% in pre-B-ALL vs 2% in common ALL; Table 1 ). Moreover, cross-lineage TCR gene rearrangements are rare (Ͻ5%) in mature B cell malignancies, such as chronic lymphocytic leukemias (CLL) or non-Hodgkin's lymphomas (NHL). 6, 31, 32 The occurrence of cross-lineage TCR gene rearrangements in precursor-B-ALL can be explained in several ways. Based on the fact that cross-lineage TCR gene rearrangements seem to be rare in normal precursor-B cells, TCR gene rearrangements may only occur in early precursor cells and the occurrence of TCR gene rearrangements in precursor-B cells may stop their further differentiation and maturation. 6 As a consequence, similarly to cortical thymocytes in the thymus, a large fraction of proliferating, immature BM precursor-B cells without functional IGH rearrangement and/or with cross-lineage TCR gene rearrangements undergo apoptosis unless they become neoplastic. 3, 33, 34 However, this would imply that oncogenic transformation preferentially affects precursor-B cells with cross-lineage TCR gene rearrangements. An alternative explanation could be that cross-lineage TCR gene rearrangements in precursor-B-ALL result from the continuing activity of the V(D)J recombinase system after the malignant transformation and maturation arrest. 3 We favor the latter hypothesis, since this would explain the low frequency of cross-lineage TCR gene rearrangements in normal precursor-B cells and in mature B cell malignancies. From our data it is also apparent that common ALL is a seemingly distinct subentity with a highly active recombination machinery and accessible Ig and TCR genes. In very immature B cells (pro-B-ALL) and more mature B cells (pre-B-ALL, B-CLL and B-NHL) the V(D)J recombinase is less active and the mature B cell malignancies have already passed the lineage commitment point so that TCR genes are not accessible any more and rearrangements are no longer possible.
Owing to their enormous diversity, junctional regions of rearranged Ig and TCR genes represent ideal PCR targets for the detection of MRD. 14, 17, 35 In precursor-B-ALL, this especially concerns junctional regions of IGH, IGK, TCRG and TCRD genes. 15 For this purpose the precise configuration of the gene rearrangements (ie the V(D), and J gene segments) has to be identified at diagnosis. We determined the frequency of precursor-B-ALL, which have an identifiable type of TCRG (59%) and/or TCRD (49%) gene rearrangement, and found that in at least 79% (159/202) of precursor-B-ALL one or more rearranged TCRG and/or TCRD genes can be used as targets for PCR-mediated MRD detection. In 55% of patients even two TCRG and/or TCRD targets were present.
Comparative SB and heteroduplex PCR analysis of TCRG Cross-lineage TCR gene rearrangements in precursor-B-ALL T Szczepański et al 203 Table 5 Comparison of TCR gene rearrangements as detected by SB analysis in childhood precursor-B-ALL from our data and data reviewed from the literature and TCRD in 62 patients showed concordance of approximately 80% between the two techniques. One explanation for the discrepancies is the efficient PCR detection of rearrangements derived from small subclones, which are difficult to detect by SB. Secondly, 15 rearrangements to the D␦3/J␦1 region as detected by SB could not be assigned to a particular V␦-J␦ joining based on the sizes of clonal bands. In those cases no clonal PCR products were found with the TCRD applied primer sets. These rearrangements probably reflect V␣-J␦1 rearrangements or translocations into the TCRD locus. Furthermore, four precursor-B-ALL patients with seemingly 'clonal V␦2-D␦3 bands' on SB analysis revealed an oligoclonal pattern by heteroduplex PCR analysis.
Based on combined SB/PCR data and on reports from the literature the frequency of cross-lineage TCR oligoclonality in precursor-B-ALL can be estimated to be ෂ20%. This seems to be significantly lower as compared to IGH, where multiple rearranged IGH gene bands, generally differing in density, were found in 30-40% of patients. [36] [37] [38] [39] [40] [41] However, when focusing on the group of patients with TCRG and TCRD rearrangements, the frequency of oligoclonality is comparable with the IGH gene. Taking into account IGH oligoclonality and the relative instability of IGH rearrangements, [36] [37] [38] 42, 43 TCR gene rearrangements seem to be at least equally suitable MRD-PCR targets. The stability of the leukemia-specific TCR gene junctional regions is reasonably high as found in studies of ALL patients at diagnosis and relapse, which showed that in 80-90% of leukemias at least one rearranged TCR allele remained stable. 37, 44, 45 Heteroduplex PCR analysis appeared to be a valuable method for the identification of TCRG and TCRD MRD-PCR targets. This method is more rapid and less expensive than SB analysis and requires only small amounts of DNA. Heteroduplex PCR data indicate that MRD monitoring is possible using TCRG and TCRD targets in approximately 80% of childhood precursor-B-ALL patients. Nevertheless, reliable quantitative molecular techniques such as TaqMan technology are needed to distinguish between rearrangements from major and minor subclones. 46 Our study indicates that cross-lineage TCR gene rearrangements and/or deletions in childhood precursor-B-ALL occur at high frequency, in a hierarchical order, and are incomplete in a large number of cases (TCRB and TCRD genes). In at least 79% of precursor-B-ALL one or more of the TCRG and TCRD gene rearrangements can be identified and can be used as targets for PCR-mediated MRD detection. Based on the combined data it is also possible to reduce the broad panel of six TCRD and 12 TCRG primer combinations to two TCRD combinations (V␦2-D␦3 and D␦2-D␦3) and six TCRG combinations (V␥I, V␥II, V␥IV family-specific primers with J␥1.1/2.1 and J␥1.3/2.3 primers) resulting in the detection of 80% and 97% of all TCRD and TCRG gene rearrangements, respectively.
